Role of viruses in asthma

Keyphrases

• Airway Epithelial Barrier 16%
• Airway Microbiome 16%
• Anti-respiratory Syncytial Virus 16%
• Asthma 100%
• Asthma Development 33%
• Asthma Exacerbation 33%
• Asthma Treatment 16%
• Atopic Asthma 33%
• Breathing Difficulties 16%
• Bronchiolitis 16%
• Causative Agents 16%
• CDHR3 16%
• Common Cold 16%
• Corticosteroids 16%
• Environmental Exposure 16%
• Environmental Risk Factors 16%
• Fish Oil 16%
• Genotype 16%
• Illness 16%
• Inflammation 16%
• Inflammatory Environment 16%
• Inflammatory Mechanisms 16%
• Interferon Response 16%
• Monoclonal Antibody 16%
• Nutritional Deficiency 16%
• Oil Increase 16%
• Omalizumab 16%
• Palivizumab 16%
• Personal Risk Factors 16%
• Recurrent Wheeze 16%
• Respiratory Syncytial Virus 50%
• Respiratory Viral Infection 16%
• Rhinovirus 100%
• Risk Factors 16%
• Risk Genes 16%
• Specific Risk 16%
• Unique Mechanism 16%
• Viral Factors 16%
• Viral Illness 16%
• Virus 100%
• Virus Infection 16%
• Vitamin D 16%
• Wheezing 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Allergic Asthma 22%
• Asthma 100%
• Bronchiolitis 11%
• Disease 22%
• Dyspnea 11%
• Environmental Exposure 11%
• Fish Oil 11%
• Human Respiratory Syncytial Virus 44%
• Human Rhinovirus 11%
• Infectious Agent 11%
• Inflammation 11%
• Interferon 11%
• Microbiome 11%
• Monoclonal Antibody 11%
• Nutritional Deficiency 11%
• Omalizumab 11%
• Palivizumab 11%
• Rhinovirus 66%
• Viral Respiratory Tract Infection 11%
• Virus Infection 11%
• Vitamin D 11%
• Wheezing 33%

Immunology and Microbiology

• Allergic Asthma 28%
• Asthma 100%
• Asthma Exacerbation 28%
• Bronchiolitis 14%
• Human Respiratory Syncytial Virus 57%
• Human Rhinovirus 14%
• Infectious Agent 14%
• interferon 14%
• Microbiome 14%
• Monoclonal Antibody 14%
• Omalizumab 14%
• Palivizumab 14%
• Rhinovirus 85%
• Viral Disease 42%